Karla A. Henning - Concepedia

Concepedia

Author

Karla A. Henning

Bristol-Myers Squibb (United States)ORCID

Also Known As

Henning, Karla, K A Henning, K. A. Henning, Karla A Henning, Karla A. Henning, Karla Henning

49

Publications

2.5K

Citations

13

H-Index

42

Concepts

All Affiliations

Bristol-Myers Squibb (United States)National Institutes of Health National Human Genome Research Institute Stanford University The University of Texas Southwestern Medical Center

KA

About

Karla A. Henning is an author at Bristol-Myers Squibb (United States) specializing in medicine, molecular biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2K
2	Cell Biology	4	4	1.2K
3	Natural Sciences	3	3	868
4	Immunology	2	2	1K
5	Engineering	1	1	46

Karla A. Henning

×

13

Publications

2.5K

Citations

13

H-Index

	Year	Citations
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells M. J. Selby, John Engelhardt, Michael Quigley, Cancer Immunology Research Antitumor ActivityT-regulatory CellImmunologyImmune RegulationImmunodominance	2013	848
The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH Karla A. Henning, Lei Li, Narayan V. Iyer, Cell Rna ProcessingWd Repeat ProteinNatural SciencesGeneticsProtein Genetics	1995	502
UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. David B. Bregman, Ruth Halaban, Alain J. van Gool, Proceedings of the National Academy of Sciences Transcriptional RegulationGenome InstabilityUv-induced UbiquitinationRna Polymerase IiCsb Gene Products	1996	322
BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis <i>In Vitro</i> and Shows Antitumor Activity <i>In Vivo</i> in Hematologic Malignancies Michelle Kuhne, Tanya Mulvey, Blake Belanger, Clinical Cancer Research	2012	207
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity Shelley E. Ackerman, Cecelia I. Pearson, Joshua D. Gregorio, Nature Cancer Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityAutoimmunity	2020	194
Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences Karla A. Henning, Elizabeth A. Novotny, Sheila Compton, Proceedings of the National Academy of Sciences	1999	118
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and –independent mechanisms Tatiana Pazina, Ashley M. James, Alexander W. Macfarlane, OncoImmunology	2017	81
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models Natalie Bezman, Amy Jhatakia, Alper Y. Kearney, Blood Advances	2017	53
Humanizing the yeast telomerase template Karla A. Henning, N H Moskowitz, Melissa A. Ashlock, Proceedings of the National Academy of Sciences EngineeringGeneticsMolecular BiologyMolecular GeneticsGenomics	1998	46
DNA-mediated transfer of a human DNA repair gene that controls sister chromatid exchange. Larry H. Thompson, Kerry W. Brookman, J.L. Minkler, Molecular and Cellular Biology Dna DamageCytogeneticsGeneticsMolecular BiologyEpigenetics	1985	44

Page 1